TY - JOUR
T1 - Mutant prevention concentrations of ABT-492, levofloxacin, moxifloxacin, and gatifloxacin against three common respiratory pathogens
AU - Hermsen, Elizabeth D.
AU - Hovde, Laurie B.
AU - Konstantinides, George N.
AU - Rotschafer, John C.
PY - 2005/4
Y1 - 2005/4
N2 - The purpose of this study was to compare the mutant prevention concentration (MPC) of ABT-492 to those of levofloxacin, moxifloxacin, and gatifloxacin against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis. The fluoroquinolones had comparable mutation selection windows, which is the ratio of MPC/MIC, for all isolates.
AB - The purpose of this study was to compare the mutant prevention concentration (MPC) of ABT-492 to those of levofloxacin, moxifloxacin, and gatifloxacin against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis. The fluoroquinolones had comparable mutation selection windows, which is the ratio of MPC/MIC, for all isolates.
UR - http://www.scopus.com/inward/record.url?scp=16244412602&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=16244412602&partnerID=8YFLogxK
U2 - 10.1128/AAC.49.4.1633-1635.2005
DO - 10.1128/AAC.49.4.1633-1635.2005
M3 - Article
C2 - 15793158
AN - SCOPUS:16244412602
SN - 0066-4804
VL - 49
SP - 1633
EP - 1635
JO - Antimicrobial agents and chemotherapy
JF - Antimicrobial agents and chemotherapy
IS - 4
ER -
